Becker Joel 4
4 · NeuroPace Inc · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
NeuroPace (NPCE) CEO Joel Becker Receives Equity Award
What Happened Joel Becker, CEO of NeuroPace (NPCE), received equity awards on May 15, 2026: 45,880 restricted stock units (RSUs) and 122,190 derivative awards (stock option-type award), both reported at a $0.00 acquisition price. Combined, the grants represent up to 168,070 potential shares; no cash was exchanged. These are compensation awards rather than open-market purchases or sales.
Key Details
- Transaction date: May 15, 2026; Form 4 filed May 19, 2026 (timely within the 2-business-day requirement).
- Awards reported: 45,880 RSUs (line A, $0.00) and 122,190 derivative award (line A, $0.00).
- Shares owned after transaction: Not specified in this filing.
- Footnote F1 (RSUs): Each RSU converts to one share on settlement. 25% vest on May 15, 2027; remaining RSUs vest in twelve equal quarterly installments thereafter.
- Footnote F2 (derivative/option-type award): 25% of option shares vest on May 15, 2027; remaining shares vest in 36 equal consecutive monthly installments thereafter.
- No indication of sale, tax withholding, 10b5-1 plan, or cashless exercise in this filing.
Context These grants are standard long-term compensation tied to future vesting — not immediate purchases or sales — so they reflect expected retention incentives rather than an immediate statement about market sentiment. The derivative award vests over time; the filing does not show any immediate exercise or disposition.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-15+45,880→ 142,817 total - Award
Stock Option (Right to Buy)
[F2]2026-05-15+122,190→ 122,190 totalExercise: $15.36Exp: 2036-05-14→ Common Stock (122,190 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.